20
May
2025

Nabiqasim Pharma Group

Exhibitor at CPHI Americas 2025 stand 1637
About Us

A leading pharmaceutical manufacturing company of Pakistan, delivering high quality Finished Pharmaceutical Formulations (Lyophilization, Prostaglandins, Creams, Ointments, Enemas, Tablets, Capsules, Syrups & Infusions) to the local market and across the globe. Please visit us at Stall No 5A39 #Surge Laboratories

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • PK
  • 2023
    On CPHI since
  • 2
    Certificates
  • 1000 - 4999
    Employees
Company types
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Americas 2025
  • 20 May 2025 - 22 May 2025
  • Pennsylvania Convention Center, Philadelphia
  • Visit us at stand 1637

Products Featured at CPHI Americas 2025

  • Cardiovascular

    Product Cardiovascular

    Nabiqasim offers a wide range of Cardiovascular products in combination and single ingredient including APIXABAN; RIVIROXABAN; SACUBITRIL+VALSARTAN; ROSUVASTATIN+EZETIMIBE and many others. 
  • Hypoglycemics

    Product Hypoglycemics

    Nabiqasim offers a wide range of Hypoglycemic products including DAPAGLIFLOZIN+METFORMIN HYDROCHLORIDE EXTENDED RELEASE; EMPAGLIFLOZIN + METFORMIN HYDROCHLORIDE;  EMPAGLIFLOZIN+LINAGLIPTIN+METFORMIN HYDROCHLORIDE EXTENDED RELEASE and many others
  • Lyophilization

    Product Lyophilization

    Lyophilized vials